Coherus Oncology, Inc.

CHRSNASDAQHealthcare● Active

$1.44

$-0.01(-0.61%)

Market Cap$176404937

P/E Ratio—

52W High$2.616

52W Low$0.71

Avg Volume1.3M

Open$1.47

Beta0.96

Employees Ownership Insider Trades

Coherus Oncology, Inc. (CHRS) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · CHRS · as of Mar 9, 2026

Latest filing snapshot

147

-159-51.96%vs prior year

Coherus Oncology, Inc. (CHRS) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

147

Change (1Y)

-159

Growth % (1Y)

-51.96%

Revenue / Employee

$286.9K

Net Income / Employee

$-1.16M

Market Cap

$176M

CHRS Employee Count

2014 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-03-09	2025-12-31	147	-159	-51.96%
2025-03-17	2024-12-31	306	+0	+0.00%
2024-03-15	2023-12-31	306	-53	-14.76%
2023-03-06	2022-12-31	359	+27	+8.13%
2022-02-23	2021-12-31	332	+15	+4.73%
2021-02-25	2020-12-31	317	+26	+8.93%
2020-02-27	2019-12-31	291	+59	+25.43%
2019-02-28	2018-12-31	232	+110	+90.16%
2018-03-08	2017-12-31	122	-30	-19.74%
2017-03-14	2016-12-31	152	+43	+39.45%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

Coherus Oncology, Inc.YOU

C4 Therapeutics, Inc.

Insight Molecular Diagnostics Inc.

46$162M #7

AVTX

Avalo Therapeutics, Inc.

23$148M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · CHRS peer comparison

About CHRS employees

CHRS Employees · Headcount

Coherus Oncology, Inc. (CHRS) employee data is sourced from the annual SEC 10-K filing. As of 2025, Coherus Oncology, Inc. had 147 full-time employees globally. Full-time employees only. Global consolidated headcount.

Coherus Oncology, Inc. employs 147 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $286,884, reflecting the company's operational efficiency.

Coherus Oncology, Inc.'s workforce decreased by 159 (51.96%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Coherus Oncology, Inc.'s revenue per employee of $286,884 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

CHRS Employees · 5 questions

As of the latest SEC 10-K filing (2025), Coherus Oncology, Inc. had 147 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Coherus Oncology, Inc. employee counthow many employees does Coherus Oncology, Inc. haveCHRS total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-09